Citra Borneo Utama Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp790 (market cap 2.48T, 18K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 20.37M 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 15.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (20.37M versus 18K). Which is the better fit depends on your goals.
| CBUT | DKHH | |
|---|---|---|
Market Cap | 2.48T | 160.67B |
Volume | 18K | 20.37M |
Lot | 180 | 203.7K |
Turnover | 14.34M | 1.33B |
Average Price | 796.83 | 65.3 |
Value | 14.34M | 1.33B |
Indicative Equilibrium Price | 810 | 64 |
Indicative Equilibrium Volume | 24 | 1.35K |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →